Document is current
Any future updates will be listed below
-
Authors
Kaur, Gurman https://orcid.org/0000-0001-7722-3956
Porter, Caroline B. M.
Ashenberg, Orr
Lee, Jack
Riesenfeld, Samantha J. https://orcid.org/0000-0001-9144-021X
Hofree, Matan https://orcid.org/0000-0001-8368-0299
Aggelakopoulou, Maria
Subramanian, Ayshwarya https://orcid.org/0000-0002-4134-7612
Kuttikkatte, Subita Balaram
Attfield, Kathrine E. https://orcid.org/0000-0003-3387-521X
Desel, Christiane A. E. https://orcid.org/0000-0003-2029-3851
Davies, Jessica L. https://orcid.org/0000-0002-8888-1441
Evans, Hayley G.
Avraham-Davidi, Inbal https://orcid.org/0000-0001-7118-9179
Nguyen, Lan T.
Dionne, Danielle A.
Neumann, Anna E. https://orcid.org/0000-0001-7115-8305
Jensen, Lise Torp
Barber, Thomas R.
Soilleux, Elizabeth https://orcid.org/0000-0002-4032-7249
Carrington, Mary https://orcid.org/0000-0002-2692-2180
McVean, Gil https://orcid.org/0000-0002-5012-4162
Rozenblatt-Rosen, Orit https://orcid.org/0000-0001-6313-3570
Regev, Aviv
Fugger, Lars https://orcid.org/0000-0003-2883-3226
-
Funding
Funding for this research was provided by:
Wellcome Trust (100308/Z/12/Z)
RCUK | Medical Research Council (MC_UU_12010/3)
- License Information
-
More Information
Article History
Received: 28 September 2021
Accepted: 18 July 2022
First Online: 29 July 2022
Competing interests
: A.R. is a co-founder and equity holder of Celsius Therapeutics, an equity holder in Immunitas, and was an SAB member of ThermoFisher Scientific, Syros Pharmaceuticals, Neogene Therapeutics and Asimov until July 31, 2020. From August 1, 2020, A.R. is an employee of Genentech and has equity in Roche. O.R.-R. is an employee of Genentech as of October 19, 2020 and has equity in Roche. O.A., O.R.-R. and A.R. are co-inventors on patent applications filed by the Broad Institute for inventions related to single-cell genomics, such as in PCT/US2018/060860 and US provisional application no. 62/745,259. G.M. is a director of and shareholder in Genomics plc and a partner in Peptide Groove LLP. The remaining authors declare no competing interests.
